SeaStar Medical Amends S-1 to Register 2 Million Shares for Resale by Lincoln Park, Signaling Significant Dilution for Capital Access
ICU has more than doubled off its 52-week low of $2.07.
Summary
SeaStar Medical filed an S-1/A to register an aggregate of 2,000,000 shares for resale by Lincoln Park Capital, potentially raising up to $14.66 million more for the company but also signaling significant shareholder dilution.
Key Events · Financing and Capital Events · ICU
-
Amended Resale Registration
The company filed an S-1/A to register an aggregate of 2,000,000 shares of common stock for resale by Lincoln Park Capital Fund, LLC. This amends a prior S-1 filing from April 28, 2026, which registered 1.66 million shares, by clarifying the total registered amount.
-
Substantial Potential Dilution
If all 2,000,000 registered shares are issued and sold, it would represent approximately 50.04% dilution to the 3,997,002 shares outstanding as of April 20, 2026.
-
Access to Capital
The company may receive up to an additional $14,657,887.43 in gross proceeds from sales to Lincoln Park under an existing purchase agreement, which was established on April 25, 2025, for a total commitment of $15.0 million.
-
Critical for Going Concern
This capital access is vital for SeaStar Medical, which recently disclosed substantial doubt about its ability to continue as a going concern in its 2025 annual report.
Analysis · ICU · Industrial Applications And Services
This S-1/A filing clarifies the total number of shares registered for resale by Lincoln Park Capital to 2,000,000, an increase from the 1.66 million shares previously registered. This represents a potential dilution of over 50% to existing shareholders if all shares are issued and sold. While highly dilutive, the ability to access up to an additional $14.66 million from this equity line of credit is critical for SeaStar Medical, especially given the company's recent disclosure of substantial doubt about its ability to continue as a going concern. This financing provides a necessary, albeit costly, pathway to extend the company's operational runway.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICU was trading at $4.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.4M. The 52-week trading range was $2.07 to $13.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.